Darolutamide monotherapy reduced prostate-specific antigen response in patients with hormone-sensitive prostate cancer while maintaining testosterone levels in a recent 24-week randomized study.
This week’s COVID-19 roundup coverage includes national trends in mortality due to alcohol use disorder during the pandemic, as well as the impact of hormone replacement therapy on COVID-19 mortality and...
The American College of Physicians has released a new guideline on the benefits and harms of testosterone treatment in men with age-related low testosterone.
In a new systematic review and meta-analysis, McMaster University researchers explored the impact of hormone therapy on muscle mass in postmenopausal women.
NPS Pharmaceuticals Inc's hormone replacement therapy Natpara appears effective, though data from one clinical trial site was excluded due to manufacturing violations, according to a preliminary report...
